Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Prognostic factors of colorectal cancer patients with brain metastasesRadiotherapy & Oncology, 2021, 158, pp.67-73. ⟨10.1016/j.radonc.2021.02.006⟩
Journal articles
hal-03237457v1
|
||
|
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France TrialClinical Cancer Research, 2021, 27 (20), pp.5638-5646. ⟨10.1158/1078-0432.CCR-21-0271⟩
Journal articles
inserm-03405591v1
|
||
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III TrialJournal of Clinical Oncology, 2018, 36 (15), pp.1469-1477. ⟨10.1200/JCO.2017.76.0355⟩
Journal articles
hal-01951156v1
|